Sexually transmitted diseases and HIV. A female perspective

Dermatol Clin. 1998 Oct;16(4):847-51, xv-xvi. doi: 10.1016/s0733-8635(05)70059-0.

Abstract

Sexually transmitted diseases have the greatest impact on the health of women. They are frequently asymptomatic, so screening for infection is important in preventing the long-term sequelae which include infertility, ectopic pregnancy, and chronic pelvic pain. HIV continues to increase in the female population and the gynecologic complications associated with it are unique to this population. Use of zidovudine in pregnant HIV-infected women has substantially decreased the rate of vertical transmission of HIV infection. The epidemiologic synergy between HIV and STDs is well recognized and prevention of one is dependent on prevention of the other.

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Epidemiologic Factors
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control
  • HIV Infections / transmission*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Infertility, Female / etiology
  • Infertility, Female / prevention & control
  • Male
  • Pelvic Pain / etiology
  • Pelvic Pain / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy, Ectopic / etiology
  • Pregnancy, Ectopic / prevention & control
  • Sexually Transmitted Diseases, Viral / complications
  • Sexually Transmitted Diseases, Viral / epidemiology
  • Sexually Transmitted Diseases, Viral / prevention & control*
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / prevention & control
  • Women's Health*
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Zidovudine